Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

Bullboard (TSXV:SBM)

View:
Prev ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... Next
Comment by Pareto8020on Apr 25, 2023 7:06am

RE:News without news😃

OMG - they can't even get a news release done properly!   At what point is someone at SBM going to be shown the door for incompetence!!?? So they have major material news and they ...more  
50
Discussion
Comment by SleepyHowardon Apr 25, 2023 6:48am

RE:News without news😃

Was it a mistake to put the homepage online?  You never know with this unprofessionell management. Waiting for the news.  Bought more shares
49
Discussion
Post by SleepyHowardon Apr 25, 2023 6:45am

News without news😃

The following results were recently obtained: Clinical Trial Results TFC-1326 • Increased Skin Density (Collagen and Elastin) by 37%  • Decreased inflammation by 54% • Decreased oxidation ...more  
228
Discussion
Comment by PeterGon Apr 25, 2023 12:48am

RE:biotech is slow and cool

Good statement, but a disagree with your last sentence. 10 years instead of 2 years. Howard did the same mistake not once, not twice but several times since a decade now. And that worried me a bit ...more  
57
Discussion
Comment by emerald03on Apr 24, 2023 5:38pm

RE:biotech is slow and cool

WE ,THE MARKET, AND PRIVATE SHAREHOLDERS DESERVE AN UPDATE NOW ON THE ANTIAGING TRIAL - why are the  trial data statisticians taking more time, they have had approximately 7 weeks already ,so ...more  
88
Discussion
Comment by SleepyHowardon Apr 24, 2023 2:18pm

RE:biotech is slow and cool

Very great tweet.  That is what I am looking for after years of tears
46
Discussion
Post by biorunon Apr 24, 2023 2:12pm

biotech is slow and cool

Until it's not. This is what I would like to see: Anti aging results that draw competitive interest from the big cats Evidence of product launch with AbbVie 1067 Royalty rate disclosure ...more  
266
Discussion
Comment by SleepyHowardon Apr 24, 2023 12:55pm

RE:It's the market's fault you dum-dum's!

So true.  It can be so easy to do something for the shareholders and the share prize. Change the ceo and we will see 100% plus or more. He told us less upfront for more royalties what a bullshit ...more  
85
Discussion
Comment by PeterGon Apr 24, 2023 12:03pm

RE:It's the market's fault you dum-dum's!

Good point. Not just Howard, the whole management has failed except Geraldine and the French science team. So I'm so scared to think about the fact that maybe we get good AA data but the same ...more  
51
Discussion
Comment by PeterGon Apr 22, 2023 2:21am

RE:What next?

Maybe Sirona eventually presents a deal with a partner to treat diabetes for fat cats?! This deal is very close now since 4 years. 
64
Discussion
Comment by forhandlarenon Apr 21, 2023 6:01pm

RE:What next?

I place my bet on a Abbvie milestone that would trigger payment. Could be tied to first delivery of compound at a fixed date?
66
Discussion
Comment by emerald03on Apr 21, 2023 5:50pm

RE:One thing we know

well if  one month is the case, then makes me wonder if the trial data  was not  anticipated to be as expected . They may have had a hint as it was a very small trial with a contract ...more  
68
Discussion
Comment by forhandlarenon Apr 21, 2023 4:45pm

RE:Q&a

Geraldine is expected to be on the next Q&A - makes sense to wait until anti-aging clinical trial results are communicated.  This is a potential block-buster, but time will tell!
62
Discussion
Comment by biorunon Apr 21, 2023 1:35pm

RE:RE:RE:Brad, the German

Can't argue with the facts as they have presented themselves to us.  The only reason we are here is to make money in the future, and that is the play here.
61
Discussion
Prev ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities